Back to Search
WILLIAM HARDIE, MD
MD
Pediatric Pulmonology Physician
NPI: 1518048743IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Pulmonology PhysicianPrimary
Pediatrics — Pediatric Pulmonology
Code: 2080P0214X
35.062096(OH)
Education
VANDERBILT UNIVERSITY SCHOOL OF MEDICINE
Class of 1990
Research & Publications (20)
EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis.
PMID 18424623·Am J Physiol Lung Cell Mol Physiol·2008
7-preclinical
Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis.
PMID 17496152·Am J Respir Cell Mol Biol·2007
7-preclinical
Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis.
PMID 14660483·Am J Physiol Lung Cell Mol Physiol·2004
7-preclinical
Dose-related protection from nickel-induced lung injury in transgenic mice expressing human transforming growth factor-alpha.
PMID 11919079·Am J Respir Cell Mol Biol·2002
7-preclinical
Dose-dependent lung remodeling in transgenic mice expressing transforming growth factor-alpha.
PMID 11597899·Am J Physiol Lung Cell Mol Physiol·2001
7-preclinical
Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production.
PMID 19661247·Am J Respir Crit Care Med·2009
7-preclinical
Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis.
PMID 19244201·Am J Respir Cell Mol Biol·2009
7-preclinical
Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice.
PMID 19188657·Am J Respir Cell Mol Biol·2009
7-preclinical
Surfactant-associated protein B is critical to survival in nickel-induced injury in mice.
PMID 19131640·Am J Respir Cell Mol Biol·2009
7-preclinical
Acceptability and repeatability of spirometry in children using updated ATS/ERS criteria.
PMID 18785259·Pediatr Pulmonol·2008
8-other
Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.
PMID 18006877·Am J Respir Cell Mol Biol·2008
7-preclinical
Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis.
PMID 17468132·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
Long-term results of microwave thermotherapy for symptomatic benign prostatic hyperplasia.
PMID 16359213·J Endourol·2005
4-observational
TGF-alpha perturbs surfactant homeostasis in vivo.
PMID 15764643·Am J Physiol Lung Cell Mol Physiol·2005
7-preclinical
Transient induction of TGF-alpha disrupts lung morphogenesis, causing pulmonary disease in adulthood.
PMID 15090366·Am J Physiol Lung Cell Mol Physiol·2004
7-preclinical
Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha.
PMID 12896876·Am J Physiol Lung Cell Mol Physiol·2003
7-preclinical
Acute lung injury: functional genomics and genetic susceptibility.
PMID 11893692·Chest·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3333 BURNET AVE, ML 2021
CINCINNATI, OH 45229 - Phone
- (513) 636-6771
Quick Facts
- NPI
- 1518048743
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile